NP
Neopenda, PBC
SEC filingBiotechnology · Chicago, IL
Amount raised$215Ksold at filing
Total offering$500K$285K still open
Investors in the raise8count reported to the SEC
FiledAug 27, 2026first sale Aug 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Zachary SeavernsDirector
Sona ShahExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.